Lv41
720 积分 2024-01-14 加入
Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir
2小时前
待确认
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells
2小时前
待确认
Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity
7天前
已完结
FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review
11天前
已完结
Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations
12天前
已完结
Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast Cancer
29天前
已完结
Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC
1个月前
已完结
Acetylene Group, Friend or Foe in Medicinal Chemistry
1个月前
已完结
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
1个月前
已完结
Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors
2个月前
已完结
皖公网安备34019202002308
